Thomas Gad, CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc. (YMAB), sold 70,000 shares at $12.03 ($841K) on 2024-06-10, disclosed to the SEC on 2024-06-11.
Seasonal sale ($841k) by CHIEF BUSINESS OFFICER — this insider has traded YMAB in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.03 | 35,000 | $421K | 50.1% |
| 2 | $12.00 | 35,000 | $420K | 49.9% |
| Total | $12.02 avg | 70,000 | $841K | 100% |
| Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |
| YMAB | SELL | 2023-12-15 | $1.0M | — | Filing → |